Techniques in Vascular & Interventional Radiology
Volume 9, Issue 1 , Pages 36-39 , March 2006

The Use of Botox® in Interventional Radiology

  • John D. Bennett, MDCM, FRCPC

      Affiliations

    • CML Health Care Inc., London, Ontario, Canada.
    • Corresponding Author InformationAddress reprint requests to John D. Bennett, MDCM, FRCPC, CML Health Care Inc., 279 Wharncliffe Rd. North Unit 111, London, Ontario, Canada, N6H 2C2.
    • ,
  • Thomas A. Miller, MD, FRCPC

      Affiliations

    • Department Of Physical Medicine and Rehabilitation, University of Western Ontario Schulich School Of Medicine and Dentistry, St. Joseph’s Health Care, London, Ontario, Canada
    • ,
  • Robert S. Richards, MD, FRCSC

      Affiliations

    • Department of Surgery, Division of Plastic Surgery, University of Western Ontario Schulich School Of Medicine and Dentistry, St. Joseph’s Health Care, London, Ontario, Canada.

References 

  1. Frueh BR, Felt DP, Wojno TH, et al. Treatment of blepharospasm with botulinum toxin (A preliminary report). Arch Ophthalmol. 1984;102:1464–1468
  2. Montecucco C, Schiavo G. Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol. 1994;13:1–8
  3. Duchen LW, Strich S. The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Q J Exp Physiol Cogn Med Sci. 1968;53:8–89
  4. Jabor MA, Kaushik R, Shayani P, et al. Efficacy of reconstituted and stored botulinum toxin type A: An electrophysiologic and visual study in the auricular muscle of the rabbit. Plast Reconstr Surg. 2003;111:2419–2426
  5. Solheim LF, Siewers P, Paus B. The piriformis muscle syndrome (Sciatic nerve entrapment treated with section of the piriformis muscle). Acta Orthop Scand. 1981;52:73–75
  6. Durrani Z, Winnie AP. Piriformis muscle syndrome: An underdiagnosed cause of sciatica. J Pain Symptom Manage. 1991;6:374–379
  7. Fanucci E, Masala S, Sodani G, et al. CT-guided injection of botulinic toxin for percutaneous therapy of piriformis muscle syndrome with preliminary MRI results about denervative process. Eur Radiol. 2001;11:2543–2548
  8. Barton PM. Piriformis syndrome: A rational approach to management. Pain. 1991;47:345–352
  9. Jankiewicz JJ, Hennrikus WL, Houkom JA. The appearance of the piriformis muscle syndrome in computed tomography and magnetic resonance imaging (A case report and review of the literature). Clin Orthop Relat Res. 1991;262:205–209
  10. Fishman SM, Caneris OA, Bandman TB, et al. Injection of the piriformis muscle by fluoroscopic and electromyographic guidance. Reg Anesth Pain Med. 1998;23:554–559
  11. Childers MK, Wilson DJ, Gnatz SM, et al. Botulinum toxin type A use in piriformis muscle syndrome: A pilot study. Am J Phys Med Rehabil. 2002;81:751–759
  12. Fishman LM, Anderson C, Rosner B. Botox® and physical therapy in the treatment of piriformis syndrome. J Phys Med Rehabil. 2002;81:936–942
  13. Lang AM. Botulinum toxin type B in piriformis syndrome. Am J Phys Med Rehabil. 2004;83:198–202
  14. Cote TR, Mohan AK, Polder JA, et al. Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005;53:407–415
  15. Andrew C. Markey: Botulinum A exotoxin in cosmetic dermatology. Clin Exp Dermatol. 2000;25:173–175
  16. Hankins CL, Strimling R, Rogers GS. Botulinum A toxin for glabellar wrinkles (Dose and response). Dermatol Surg. 1998;24:1181–1183
  17. Goodman G. Botulinum toxin for the correction of hyperkinetic facial lines. Australas J Dermatol. 1998;39:158–163
  18. Carruthers A, Carruthers J, Cohen J. A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides. Dermatol Surg. 2003;29:461–467

PII: S1089-2516(06)00031-X

doi: 10.1053/j.tvir.2006.08.008

Techniques in Vascular & Interventional Radiology
Volume 9, Issue 1 , Pages 36-39 , March 2006

Article Tools

* Image Usage & Resolution